Unknown

Dataset Information

0

Long-term cross-validation of everolimus therapeutic drug monitoring assays: the Zortracker study.


ABSTRACT: This ongoing academic collaboration was initiated for providing support to set up, validate, and maintain everolimus therapeutic drug monitoring assays and to study long-term interlaboratory performance.This study was based on EDTA whole blood samples collected from transplant patients treated with everolimus in a prospective clinical trial. Samples were handled under controlled conditions during collection, storage and were shipped on dry ice to minimize freeze-thaw cycles. For more than 1.5 years, participating laboratories received a set of 3 blinded samples on a monthly basis. Among others, these samples included individual patient samples, patient sample pools to assess long-term performance, and patient samples pools enriched with isolated everolimus metabolites.The results between liquid chromatography coupled with tandem mass spectrometry (LC-MS/MS) and the everolimus Quantitative Microsphere System (QMS, Thermo Fisher) assay were comparable. The monthly interlaboratory variability (coefficient of variation %) for cross-validation samples ranged from 6.5% to 23.2% (average of 14.8%) for LC-MS/MS and 4.2% to 26.4% (average of 11.1%) for laboratories using the QMS assay. A blinded long-term pool sample was sent to the laboratories for 13 months. The result was 5.31 ± 0.86 ng/mL (range, 2.9-7.8 ng/mL) for the LC-MS/MS and 5.20 ± 0.54 ng/mL (range, 4.0-6.8 ng/mL) for QMS laboratories. Enrichment of patient sample pools with 5-25 ng/mL of purified everolimus metabolites (46-hydroxy everolimus and 39-O-desmethyl everolimus) did not affect the results of either LC-MS/MS or QMS assays.Both LC-MS/MS and QMS assays gave similar results and showed similar performance, albeit with a trend toward higher interlaboratory variability among laboratories using LC-MS/MS than the QMS assay.

SUBMITTER: Schniedewind B 

PROVIDER: S-EPMC4820066 | biostudies-literature | 2015 Jun

REPOSITORIES: biostudies-literature

altmetric image

Publications

Long-term cross-validation of everolimus therapeutic drug monitoring assays: the Zortracker study.

Schniedewind Björn B   Niederlechner Stefanie S   Galinkin Jeffrey L JL   Johnson-Davis Kamisha L KL   Christians Uwe U   Meyer Eric J EJ  

Therapeutic drug monitoring 20150601 3


<h4>Background</h4>This ongoing academic collaboration was initiated for providing support to set up, validate, and maintain everolimus therapeutic drug monitoring assays and to study long-term interlaboratory performance.<h4>Methods</h4>This study was based on EDTA whole blood samples collected from transplant patients treated with everolimus in a prospective clinical trial. Samples were handled under controlled conditions during collection, storage and were shipped on dry ice to minimize freez  ...[more]

Similar Datasets

| S-EPMC8585800 | biostudies-literature
| S-EPMC2846282 | biostudies-literature
| S-EPMC6329504 | biostudies-literature
2016-12-22 | GSE85801 | GEO
| S-EPMC6591631 | biostudies-literature
| S-EPMC5177677 | biostudies-literature
| S-EPMC9237009 | biostudies-literature
| S-EPMC4896980 | biostudies-other
| S-EPMC5204259 | biostudies-literature
2016-12-22 | GSE39693 | GEO